Results 241 to 250 of about 161,793 (289)

Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches. [PDF]

Blood Res
Lima K, Nogueira FL, Reis-Silva CSM, de Cássia Cavaglieri R, Costa-Lotufo LV, Machado-Neto JA, Rego EM.   +6 more
europepmc   +1 more source

Homoharringtonine Promotes FTO Degradation to Suppress LILRB4‐Mediated Immune Evasion in Acute Monocytic Leukaemia

Cell Proliferation, EarlyView.
Homoharringtonine (HHT) suppresses immune evasion in acute monocytic leukaemia (AML‐M5) by attenuating the FTO/m6A/LILRB4 axis, thereby enhancing CD8+ T cell cytotoxicity. ABSTRACT Acute monocytic leukaemia, a subtype of acute myeloid leukaemia (AML), is a highly aggressive malignancy characterised by a poor prognosis, primarily due to the ability of ...
Fangfang Huang, Xiang Luo, Mengyu Zhang, Le Jin, Wenxin Sun, Peihan Chen, Xiuli Hong, Chenyu Xu, Meizhi Jiang, Die Hu, Bin Zhang, Shengwei Hu, Chuanjiang Yang, Rui Gao, Jinzhang Zeng, Quanyi Lu, Qiang Luo, Jun Wu, Siming Chen   +18 more
wiley   +1 more source

Diagnostic and Prognostic Significance of miR-155, miR-181, miR-221, miR-222, and miR-223 Expression in Myelodysplastic Syndromes and Acute Myeloid Leukemia. [PDF]

Diagnostics (Basel)
Ardıç C, Ay ME, Çevik K, Tombak A, İzci Ay Ö, Karakaş Ü, Doğru Özdemir G, Bilgiç A, Erdal ME.   +8 more
europepmc   +1 more source

AML in the Spotlight: Compliance Risks for Broker-Dealers and Investment Advisers

, 2013
John H. Walsh, Cecilia Baute Mavico
openalex   +1 more source

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Integrative Bioinformatics Reveals Novel Molecular Mechanisms and Therapeutic Targets in Acute Myeloid Leukaemia. [PDF]

J Cell Mol Med
Daniel MM, Andwey GH.
europepmc   +1 more source

Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan

British Journal of Haematology, EarlyView.
Takafumi Furumoto, Koji Ando, Eo Toriyama, Tomoko Hata, Hikaru Sakamoto, Masahiko Chiwata, Hideaki Kitanosono, Jun Nakashima, Takeharu Kato, Masataka Taguchi, Makiko Horai, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Daisuke Imanishi, Yoshitaka Imaizumi, Tatsuro Jo, Shinichiro Yoshida, Yukiyoshi Moriuchi, Yasushi Miyazaki   +19 more
wiley   +1 more source

ELK1 promotes the progress of myeloid leukemia by hindering the differentiation of neutrophils. [PDF]

Exp Hematol Oncol
He Y, Zhou Y, Wen D, Guo R, Du J, Huang S, Dong Y.   +6 more
europepmc   +1 more source

A 5‐month‐old infant with a pineal tumor

Brain Pathology, EarlyView.
Fabien Forest, Martin Hasselblatt, Fanélie Barral‐Clavel, Alix Clemenson, Sandrine Thouvenin, Claire Berger, Anne Mc Leer, Catherine Godfraind   +7 more
wiley   +1 more source

NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort. [PDF]

Hematol Oncol
Vetro C, Azzali I, Petracci E, Papayannidis C, Eleuteri E, Palumbo FE, Federico V, Fracchiolla N, Zappasodi P, Martelli MP, Giannini MB, Brunetti L, Palmieri R, Nanni J, Simonetti G, Guolo F, Minetto P, Maurillo L, Gigli F, Billio A, Todisco E, Martinelli G, Marconi G.   +22 more
europepmc   +1 more source